1. Raghu G, Collard H, Egan J, Martinez F, Behr J, Brown K, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6): 788–824.
2. Yount S, Beaumont J, Chen S, Kaiser K, Wortman K, Van Brunt D, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis. Lung. 2016;194(2): 227–34.
3. National Institute for Health and Care Excellence. The diagnosis and management of suspected idiopathic pulmonary fibrosis. NICE clinical guidelines,2013;163: www.nice.org.uk/guidance/cg163/evidence/full-guideline-190086877.Accessed 01 December 2015
4. Navaratnam V, Fleming K, West J, Smith C, Jenkins R, Fogarty A, et al. The rising incidence of idiopathic pulmonary fibrosis in the UK. Thorax. 2011;66(6): 462–7.
5. Raghu G, Chen S, Hou Q, Yeh W, Collard H. Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old. Eur Respir J. 2016;48(1): 179–86.
6. Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur Respir Rev. 2012;21(126): 355–61.
7. Interstitial Lung Disease Group of Chinese Society of Respiratory Disease. Summary of the sixth national symposium on respiratory diseases in China. Chin J Tubere Respir Dis. 2004; 27, 858–61.
8. Wei L, Peng S, Cao J, Liu G, Lai Y, Jia W. Clinical features and. diagnosis and treatment of diffuse interstitial lung disease: a multi-center study. Chin Gen Prac. 2012;15: 2521–4.
9. British Lung Foundation. Lost in the system. IPF: the patient experience in. England. https://www.blf.org.uk/sites/default/files/BLF-IPF-Report-2015---Lost-in-the-System---250215.pdf on 15 March 2019.
10. Collard H, Chen S, Yeh W, Li Q, Lee Y, Wang A, et al. Health care utilization and costs in idiopathic pulmonary fibrosis in United States medicare beneficiaries aged 65 years and older. Ann Am Thorac Soc. 2015;12(7): 981–7.
11. Sampson C, Gill B, Harrison N, Nelson A, Byrne A. The care needs. of patients with idiopathic pulmonary fibrosis and their carers (CaNoPy): results of a qualitative study. BMC Pulmonary Medicine. 2015; 4(15): 155.
12. Schoenheit G, Becattelli I, Cohen A. Living with idiopathic pulmonary fibrosis: an in-depth qualitative survey of European patients. Chron Respir Dis. 2011;8(4), 225–31.
13. Overgaard D, Kaldan G, Marsaa K, Nielsen T, Shaker S, Egerod I. The lived experience with idiopathic pulmonary fibrosis: a qualitative study. Eur Respir J. 2016; 47(5): 1472–80.
14. Zhao X, Yu L, Xu W, Zhang Y. Quality of life anxiety and depression in patients with interstitial lung disease. Chin Ment Heal J. 2012;26(8): 601–4.
15. Lederer D, Martinez F. Idiopathic pulmonary fibrosis. N Engl J Med. 2018;379(8): 797–8.
16. Collard H, Tino G, Noble P, Shreve M, Michaels M, Carlson B, et al. Patient experiences with pulmonary fibrosis. Respir Med. 2007; 101(6): 1350–4.
17. Duck A, Spencer L, Bailey S, Leonard C, Ormes J, Caress A, et al. Perceptions, experiences and needs of patients with idiopathic pulmonary fibrosis. J Adv Nurs. 2015; 71(5): 1055–65.
18. Raghu G, Richeldi L. Current approaches to the management of idiopathic pulmonary fibrosis. Respir Med. 2017;129: 24–30.
19. Burnett K, Glaspole I, Holland A. Understanding the patient's experience of care in idiopathic pulmonary fibrosis. Respirology. 2019; 24(3), 270–7.
20. Smith J, Flowers P, Larkin M. Interpretative phenomenological analysis: theory, method and research. Sage Publications Ltd, London, 2019.
21. Liamputtong, P. Qualitative Research Methods. 4th ed. Melbourne: Oxford. University Press, 2013.
22. Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006;3(2): 77–101.
23. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): A 32‐item checklist for interviews and focus groups. International J Qual Health Care. 2007;19(6): 349–57. https://doi.org/10.1093/intqhc/mzm042
24. Graneheim U, Lundman B. Qualitative content analysis in nursing research concepts, procedures and measures to achieve trustworthiness. Nurs Educ Today. 2004; 24(2): 105–12.
25. Cosgrove G, Bianchi P, Danese S, Lederer D. Barriers to timely diagnosis of interstitial lung disease in the real world: the intensity survey. BMC Pulmonary Medicine. 2018;18(1): 9.
26. Li X, Lu J, Hu S, Cheng K, De Maeseneer J, Meng Q, et al. The primary health-care system in China. Lancet. 2017; 390(10112), 2584–94.
27. Qian G. Efforts to improving the diagnosis and treatment of respiratory disease in China. Chin J Lung Dis (Electric Edition). 2012; 5(1), 1–3.
28. The Idiopathic Pulmonary Fibrosis Clinical Research Network. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012; 366(21), 1968–77.
29. Ryerson C, Arean P, Berkeley J, Carrieri-Kohlman V, Pantilat S, Landefeld C, et al. Depression is a common and chronic comorbidity in patients with interstitial lung disease. Respirology. 2012;17(3): 525–32.
30. National Institute of Health and Care Excellence. Idiopathic pulmonary fibrosis in adults: diagnosis and management, 2017.
www.nice.org.uk/guidance/cg163.
31. National Institute for Health and Care Excellence. Quality Standard 79, Idiopathic pulmonary fibrosis in adults, 2015.
32. Russell A, Ripamonti E, Vancheri C. Qualitative European survey of. patients with idiopathic pulmonary fibrosis: patients’ perspectives of the disease and treatment. BMC Pulmonary Medicine. 2016;14(16): 10.
33. Cao J, Li J, He Q, Liu G, Liu Y, Wu X. The survey of the construction of specialist nurses un third-grade class A hospitals in China. Chinese Journal of Nursing. 2015;50(11): 1349–53.
34. Fu J, Xia H. A bibliometric analysis of specialty nurses training and practice status in China. Chin J Nurs Edu. 2016;13(9): 689–92.
35. Bajwah S, Higginson I, Ross J, Wells A, Birring S, Riley J, et al. The palliative care needs for the fibrotic interstitial lung disease: a qualitative study of patients, informal caregivers and health professionals. Palliat Med.2013; 27(9): 869–76.
36. Evans L, Boyd E, Malvar G, Apatira L, Luce J, Lo B, et al. Surrogate decision-makers' perspectives on discussing prognosis in the face of uncertainty. Am J Respir Crit Care Med. 2009;179(1): 48–53.
37. Braddock C. Supporting shared decision making when clinical evidence is low. Med Care Res Rev. 2013; 70: 129S–40.
38. Sun Y, Gregersen H, Yuan W. Chinese health care system and clinical epidemiology. Clinical Epidemiology. 2017; 9: 167–78.
39. Dowman L, McDonald C, Hill C, Lee A, Barker K, Boote C, et al. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial. Thorax. 2017;72(7): 610–9.